Real-time enrollment status for this small cell lung cancer extensive stage clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 2:11 PM UTC
| NCT Number | NCT07227597 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer Extensive Stage |
| Phase | PHASE1 |
| Target Enrollment | 170 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 21, 2026 (6 days ago) |
As of August 27, 2026: Clinical trial NCT07227597 is currently recruiting participants. This phase1 study for small cell lung cancer extensive stage is actively seeking new participants at 13 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227597 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227597 was last updated 6 days ago (August 21, 2026). HelloStudys verifies this status automatically.